Please login to the form below

Not currently logged in
Email:
Password:

Cotellic

This page shows the latest Cotellic news and features for those working in and with pharma, biotech and healthcare.

Amgen's Mvasi is first FDA-approved cancer biosimilar

Amgen's Mvasi is first FDA-approved cancer biosimilar

Roche is also in the midst of a fertile launch period for new medicines, with a clutch of new drugs - including Cotellic (cobimetinib) for melanoma, Alecensa (alectinib) for lung cancer, leukaemia

Latest news

More from news
Approximately 8 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics